CoChat

Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis

Open access
Yoon, Young Kyung, Park, Dae Won, Sohn, Jang Wook, Kim, Hyo Youl, Kim, Yeon-Sook, Lee, Chang-Seop, Lee, Mi Suk, Ryu, Seong-Yeol, Jang, Hee-Chang, Choi, Young Ju, Kang, Cheol-In, Choi, Hee Jung, Lee, Seung Soon, Kim, Shin Woo, Kim, Sang Il, Kim, Eu Suk, Kim, Jeong Yeon, Yang, Kyung Sook, Peck, Kyong Ran, Kim, Min Ja · 2016 · BMC Infectious Diseases
Cited by 34

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The purported value of empirical therapy to cover methicillin-resistant Staphylococcus aureus (MRSA) has been debated for decades. The purpose of this study was to evaluate the effects of inappropriate empirical antibiotic therapy on clinical outcomes in patients with healthcare-associated MRSA bacteremia (HA-MRSAB). METHODS: A prospective, multicenter, observational study was conducted in 15 teaching hospitals in the Republic of Korea from February 2010 to July 2011. The study subjects included adult patients with HA-MRSAB. Covariate adjustment using the propensity score was performed to control for bias in treatment assignment. The predictors of in-hospital mortality were determined by multivariate logistic regression analyses. RESULTS: In total, 345 patients with HA-MRSAB were analyzed. The overall in-hospital mortality rate was 33.0 %. Appropriate empirical antibiotic therapy was given to 154 (44.6 %) patients. The vancomycin minimum inhibitory concentrations of the MRSA isolates ranged from 0.5 to 2 mg/L by E-test. There was no significant difference in mortality between propensity-matched patient pairs receiving inappropriate or appropriate empirical antibiotics (odds ratio [OR] = 1.20; 95 % confidence interval [CI] = 0.71-2.03). Among patients with severe sepsis or septic shock, there was no significant difference in mortality between the treatment groups. In multivariate analyses, severe sepsis or septic shock (OR = 5.45; 95 % CI = 2.14-13.87), Charlson's comorbidity index (per 1-point increment; OR = 1.52; 95 % CI = 1.27-1.83), and prior receipt of glycopeptides (OR = 3.24; 95 % CI = 1.08-9.67) were independent risk factors for mortality. CONCLUSION: Inappropriate empirical antibiotic therapy was not associated with clinical outcome in patients with HA-MRSAB. Prudent use of empirical glycopeptide therapy should be justified even in hospitals with high MRSA prevalence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12879-016-1650-8

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 34

Metadata

Authors
Yoon, Y. K., Park, D. W., Sohn, J. W., Kim, H. Y., Kim, Y.-S., Lee, C.-S., Lee, M. S., Ryu, S.-Y., Jang, H.-C., Choi, Y. J., Kang, C.-I., Choi, H. J., Lee, S. S., Kim, S. W., Kim, S. I., Kim, E. S., Kim, J. Y., Yang, K. S., Peck, K. R., & Kim, M. J.
Venue
BMC Infectious Diseases
Published
2016-07-15
Volume
16
Issue
1
Pages
331-331
ISSN
1471-2334 (ISSN-L)
OpenAlex
W2472830515
Cited by
34
References
8
FWCI
1.68
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis. https://app.cochat.ai/papers/10.1186/s12879-016-1650-8
The paper
Yoon, Y. K., Park, D. W., Sohn, J. W., Kim, H. Y., Kim, Y.-S., Lee, C.-S., Lee, M. S., Ryu, S.-Y., Jang, H.-C., Choi, Y. J., Kang, C.-I., Choi, H. J., Lee, S. S., Kim, S. W., Kim, S. I., Kim, E. S., Kim, J. Y., Yang, K. S., Peck, K. R., & Kim, M. J. (2016). Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis. BMC Infectious Diseases. https://doi.org/10.1186/s12879-016-1650-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.